RSS
Dravet syndrome
Collaboration formed for development of epilepsy candidate
Laurus Synthesis and Epygenix Therapeutics have signed a collaboration agreement for the development and manufacture of EPX-100, an epilepsy candidate. Read more
Children with rare epilepsy treated with cannabis
Epidiolex, a cannabis-based drug has been used to treat children with Dravet syndrome, a rare form of epilepsy, in GW Pharmaceutical’s (GW) phase three clinical study Read more
